N
DMTK

Nuveen’s DermTech, Inc. Common Stock DMTK Stock Holding History

Nuveen’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80,698
Closed -$1.06M – 3539
2022
Q1 		$1.06M Buy
80,698
+8,894
+12% +$119K ﹤0.01% 2799
2021
Q4 		$1.1M Sell
71,804
-16,792
-19% -$403K ﹤0.01% 2832
2021
Q3 		$3.25M Sell
88,596
-6,678
-7% -$235K ﹤0.01% 2440
2021
Q2 		$3.96M Buy
95,274
+47,046
+98% +$1.93M ﹤0.01% 2357
2021
Q1 		$2.45M Buy
48,228
+13,921
+41% +$728K ﹤0.01% 2523
2020
Q4 		$1.11M Buy
34,307
+8,240
+32% +$117K ﹤0.01% 2764
2020
Q3 		$312K Hold
26,067
– – ﹤0.01% 3079
2020
Q2 		$345K Buy
+26,067
New +$340K ﹤0.01% 3013

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Nuveen's DMTK Position: Q2 2022 in Review

Nuveen sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 80,698 shares — an estimated $1.06M sold.

Nuveen first reported a position in DMTK in Q2 2020 and held it in 8 quarters. The position peaked at $3.96M in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • Nuveen reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 80,698 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $1.06M.
  • Nuveen first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Nuveen's DermTech, Inc. Common Stock position peaked at $3.96M in Q2 2021.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.